Co-Win Ventures
智源创投
Co-Win Ventures (智源创投) is a Chinese venture capital firm that appears as a co-investor alongside larger funds in early-stage deals. Elsewhere's corpus captures it participating in the Pre-A round of CAS-Ruiyi (中科睿医/CereMediTech), a medical technology company, where it followed BlueRun Ventures' lead in 2022 , and remaining on the cap table through the company's Series A+ round in late 2024 . The fund is not the subject of any dedicated profile in elsewhere's current material, so its founding date, AUM, and full portfolio remain unreported here.
AI-generated — may contain errors, please verify.
Coverage
CereMediTech Successfully Completes Series A+ Funding Round | BlueRun Ventures
Building the "New Infrastructure" for Diagnosing and Treating Neurological Disorders
BlueRun Ventures June Report | Hope Is a Sweet Waiting
Looking out from a bountiful June
BlueRun Ventures Leads Pre-A Round Worth Tens of Millions of RMB for Zhongke Ruiyi | BlueRun Ventures
Building "New Infrastructure" for Neuroscience
